These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7941468)

  • 41. Prevalence of antibody to hepatitis D virus among HBsAg-positive drug-dependent patients in Jeddah, Saudi Arabia.
    Njoh J; Zimmo S
    East Afr Med J; 1998 Jun; 75(6):327-8. PubMed ID: 9803612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results].
    Kokoreva LN; Zmyzgova AV; Shalygina NB
    Ter Arkh; 1996; 68(2):10-4. PubMed ID: 8771646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The effect of health resort treatment on biliary tract function in the early period of convalescence from viral hepatitis].
    Dragomiretskaia NV
    Vrach Delo; 1989 Nov; (11):10-2. PubMed ID: 2609567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis A and B virus immunization in HIV-infected persons.
    Laurence J
    AIDS Read; 2006 Jan; 16(1):15-7. PubMed ID: 16433468
    [No Abstract]   [Full Text] [Related]  

  • 45. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The epidemiology of hepatitis viruses B, C, and D.
    London WT; Evans AA
    Clin Lab Med; 1996 Jun; 16(2):251-71. PubMed ID: 8792071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Acute viral hepatitis A, B, C, D and E: epidemiology, etiology, diagnosis, course, prevention].
    Zarski JP; Leroy V; Maynard-Muet M
    Rev Prat; 1998 Sep; 48(14):1609-14. PubMed ID: 9814059
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changing epidemiology and spreading modalities of hepatitis delta virus infection in Greece.
    Hadziyannis SJ; Dourakis SP; Papaioannou C; Alexopoulou A; Hadziyannis ES; Gioustozi A
    Prog Clin Biol Res; 1993; 382():259-66. PubMed ID: 8502690
    [No Abstract]   [Full Text] [Related]  

  • 50. [Epidemiological studies on hepatitis A and B virus infections and hepatic dysfunction in young female methamphetamine-abusers].
    Ito H
    Arukoru Kenkyuto Yakubutsu Ison; 1984 Dec; 19(4):324-40. PubMed ID: 6537783
    [No Abstract]   [Full Text] [Related]  

  • 51. [The immunomodulating effect of microwaves and of an ultrahigh-frequency electrical field in patients with systemic lupus erythematosus].
    Sidorov VD; Pershin SB; Bobkova AS; Galenchik AI
    Vopr Kurortol Fizioter Lech Fiz Kult; 1991; (4):36-40. PubMed ID: 1792725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination.
    Romanò L; Paladini S; Tagliacarne C; Zappa A; Zanetti AR
    Vaccine; 2009 May; 27(25-26):3439-42. PubMed ID: 19200848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis delta virus infection among the tribes of the Andaman and Nicobar Islands, India.
    Murhekar MV; Murhekar KM; Arankalle VA; Sehgal SC
    Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):483-4. PubMed ID: 15910893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Combined therapy of duodenal ulcer associated with Helicobacter pylori with electromagnetic decimeter waves and colloidal bismuth subcitrate].
    Filimonov RM; Korolev IuN; Kochineva ER
    Vopr Kurortol Fizioter Lech Fiz Kult; 1993; (6):19-22. PubMed ID: 8154113
    [No Abstract]   [Full Text] [Related]  

  • 55. Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients.
    Bozdayi AM; Aslan N; Bozdayi G; Türkyilmaz AR; Sengezer T; Wend U; Erkan O; Aydemir F; Zakirhodjaev S; Orucov S; Bozkaya H; Gerlich W; Karayalçin S; Yurdaydin C; Uzunalimoğlu O
    Arch Virol; 2004 Nov; 149(11):2115-29. PubMed ID: 15503201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy.
    Filippini P; Coppola N; Pisapia R; Scolastico C; Marrocco C; Zaccariello A; Nacca C; Sagnelli C; De Stefano G; Ferraro T; De Stefano C; Sagnelli E
    AIDS; 2006 Jun; 20(9):1253-60. PubMed ID: 16816553
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [First study of hepatitis occurence in Sweden: low immunity is associated with susceptibility to infection].
    Böttiger M; Christenson B
    Lakartidningen; 1998 Apr; 95(16):1801-4. PubMed ID: 9599485
    [No Abstract]   [Full Text] [Related]  

  • 58. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H; Ayola B; Lok AS
    Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of hepatitis C virus among patients with liver disease in the Republic of Yemen.
    Al-Moslih MI; Al-Huraibi MA
    East Mediterr Health J; 2001; 7(4-5):771-8. PubMed ID: 15332778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon.
    Viana S; Paraná R; Moreira RC; Compri AP; Macedo V
    Am J Trop Med Hyg; 2005 Oct; 73(4):808-14. PubMed ID: 16222030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.